Search

Recursion Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

3.58 0.28

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.4699999999999998

Максимум

3.8

Ключови измерители

By Trading Economics

Приходи

12M

-119M

Продажби

11M

19M

EPS

-0.22

Марж на печалбата

-641.634

Служители

600

EBITDA

10M

-102M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+88.45% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

334M

2.4B

Предишно отваряне

3.3

Предишно затваряне

3.58

Recursion Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.11.2026 г., 21:02 ч. UTC

Macro Event

Recursion Pharmaceuticals, Inc. shares fell sharply today, continuing a decline since Monday's close, amid mixed signals from recent macroeconomic data releases.

9.11.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals, Inc. shares declined modestly in after-market trading, retracing from an earlier uptick and reaching a low in its one-month range.

6.11.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals, Inc. is trading higher in after-market hours, reaching its highest level since Friday's close.

5.11.2026 г., 23:22 ч. UTC

Correlated Moves

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, in line with a broader market decline and losses in the ARK Genomic Revolution ETF (ARKG).

4.11.2026 г., 21:04 ч. UTC

Correlated Moves

Recursion Pharmaceuticals shares are rising during Wednesday's session, following a broader biotechnology sector increase and strong gains in the SPDR S&P Biotech ETF.

3.11.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals, Inc. is moving higher in after-market hours, reflecting broader market gains amid strong economic data influencing Federal Reserve policy.

2.11.2026 г., 23:02 ч. UTC

Social Media
News

Recursion Pharmaceuticals appointed Fred Hassan as Chair of the Board, effective October 31, 2026, and reported positive Phase 2 data for REC-4881.

31.10.2026 г., 00:01 ч. UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, having declined from Friday's close amid volatility and stabilization near its one-month range.

30.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals, Inc. declined during after-market hours, with cumulative returns falling since Friday's close after briefly peaking earlier in the session.

29.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals, Inc. shares declined during after-market hours on Thursday, breaking a trend of higher daily closes established earlier in the week.

28.10.2026 г., 23:02 ч. UTC

Recursion Pharmaceuticals, Inc. is trading lower in after-market hours, reflecting the broader market's decline and retracing from an earlier session high.

27.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals, Inc. is declining in after-market hours, marking a significant retracement from recent highs after finishing higher for three consecutive sessions.

26.10.2026 г., 20:07 ч. UTC

Recursion Pharmaceuticals Inc shares are advancing, having reached an early peak but ultimately settling lower near the lower end of their one-month range.

24.10.2026 г., 00:01 ч. UTC

Recursion Pharmaceuticals Inc shares are trading lower in after-market hours, having retraced from a brief peak earlier in the session.

23.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

22.10.2026 г., 23:02 ч. UTC

Recursion Pharmaceuticals Inc is experiencing a significant decline in after-market trading, moving lower since Thursday's close and reaching its lowest point of the day.

21.10.2026 г., 23:51 ч. UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading lower in after-market hours, reflecting broader market trends and positioning below its 20-day moving average.

20.10.2026 г., 23:02 ч. UTC

Social Media

Recursion Pharmaceuticals Inc shares are trading modestly lower in after-market hours, with approximately $561 million in cash at the end of the quarter.

19.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, maintaining an upward trajectory since Monday's close.

17.10.2026 г., 00:01 ч. UTC

Recursion Pharmaceuticals Inc shares advanced modestly higher during after-market hours on Friday, diverging from the recent trend of higher daily closes.

16.10.2026 г., 23:06 ч. UTC

Recursion Pharmaceuticals Inc shares are modestly higher in after-market trading.

15.10.2026 г., 20:03 ч. UTC

News
Event
Macro Event

Recursion Pharmaceuticals announces a $200 million oversubscribed follow-on offering and positive updates on drug candidate REC-4881, achieving a 47% median reduction in polyp burden.

14.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, aligning with broader market losses amid rising inflation concerns and geopolitical tensions affecting oil supply.

13.10.2026 г., 23:06 ч. UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours following Tuesday's close.

12.10.2026 г., 20:02 ч. UTC

Recursion Pharmaceuticals Inc shares are sharply lower, continuing a downward trend since Friday, despite an early spike in today's trading session.

10.10.2026 г., 00:01 ч. UTC

Recursion Pharmaceuticals Inc shares advanced during after-market hours on Friday, despite earlier pulling back from a session high.

9.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from an earlier decline while remaining well above its 20-day moving average.

8.10.2026 г., 20:01 ч. UTC

News
Correlated Moves

Recursion Pharmaceuticals faces downward pressure amid significant insider transactions, including a 50k share sale by Director Borgeson Blake on October 6.

7.10.2026 г., 23:05 ч. UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower since Wednesday's close.

6.10.2026 г., 20:02 ч. UTC

Correlated Moves
Social Media
News

Recursion Pharmaceuticals Inc. shares fell amid sector declines, with attention on upcoming Phase 2 data for REC-4881 and ongoing trials for other candidates.

Сравнение с други в отрасъла

Ценова промяна

Recursion Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

88.45% нагоре

12-месечна прогноза

Среден 6.633 USD  88.45%

Висок 8 USD

Нисък 5.9 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Recursion Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

2

Купи

2

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
help-icon Live chat